{
    "id": 1153,
    "fullName": "RAF1 dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "RAF1 dec exp indicates decreased expression of the Raf1 protein and/or mRNA. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5894,
        "geneSymbol": "RAF1",
        "terms": [
            "RAF1",
            "c-Raf",
            "CMD1NN",
            "CRAF",
            "NS5",
            "Raf-1"
        ]
    },
    "variant": "dec exp",
    "createDate": "07/25/2014",
    "updateDate": "10/08/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 823,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, knockdown of C-RAF in a BRAF V600E melanoma cell line with decreased NF1 expression restored sensitivity to the MEK inhibitor selumetinib (AZD6244) (PMID: 23288408).",
            "molecularProfile": {
                "id": 1178,
                "profileName": "BRAF V600E NF1 dec exp RAF1 dec exp"
            },
            "therapy": {
                "id": 913,
                "therapyName": "Selumetinib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 473,
                    "pubMedId": 23288408,
                    "title": "A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23288408"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 821,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combined shRNA knockdown of NF1 and RAF1 in a melanoma cell line with BRAF V600E mutation was sensitive to RAF inhibitor PLX4720 (PMID: 23288408).",
            "molecularProfile": {
                "id": 1178,
                "profileName": "BRAF V600E NF1 dec exp RAF1 dec exp"
            },
            "therapy": {
                "id": 1060,
                "therapyName": "PLX4720",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 473,
                    "pubMedId": 23288408,
                    "title": "A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23288408"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7358,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Mekinist (trametinib) treatment demonstrated enhanced growth inhibition and sustained inhibition of Erk signaling in lung cancer cells harboring KRAS G12C with decreased Raf1 expression through shRNA knockdown in culture (PMID: 27338794).",
            "molecularProfile": {
                "id": 25300,
                "profileName": "KRAS G12C RAF1 dec exp"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6325,
                    "pubMedId": 27338794,
                    "title": "A combinatorial strategy for treating KRAS-mutant lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27338794"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8670,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, knocking down of Raf1 expression via shRNA sensitized BRAF mutant colorectal cancer cell lines to PLX4720 in culture (PMID: 26351322).",
            "molecularProfile": {
                "id": 26400,
                "profileName": "BRAF mut RAF1 dec exp"
            },
            "therapy": {
                "id": 1060,
                "therapyName": "PLX4720",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6708,
                    "pubMedId": 26351322,
                    "title": "Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26351322"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1178,
            "profileName": "BRAF V600E NF1 dec exp RAF1 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 8897,
            "profileName": "RAF1 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 25300,
            "profileName": "KRAS G12C RAF1 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 26400,
            "profileName": "BRAF mut RAF1 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}